Studies of the human immune system have been limited by the lack of an appropriate in vivo model. For this reason, efforts have been made to develop murine models with a functional human immune system. We report here that co-transplantation of human fetal thymus/liver tissues and CD34 + hematopoietic stem/progenitor cells lead to the development of sustained human hematopoiesis and a functional human immune system in immunodeficient NOD/SCID mice. The humanized mice showed systemic repopulation with a comprehensive array of human lymphohematopoietic cells, including T cells, B cells, and dendritic cells, and the formation of secondary lymphoid organs. Furthermore, these mice produce high levels of human IgM and IgG antibodies and mediate strong immune responses in vivo as demonstrated by skin xenograft rejection. Thus, the humanized NOD/SCID mice described in this paper provide a powerful model system to study human immune function.
Introduction
Human hematopoietic tissue and cell transplantation into immunodeficient mice, such as mice with the severe combined immunodeficiency (SCID) 1,2 mutation and their derivatives, including NOD/SCID 3 , NOD/SCID/β2m null 4 , and NOD/SCID/γc null 5 mice, has been widely used to study the function of human immune cells. However, only a few studies have shown the ability to achieve systemic in vivo immune responses in humanized mice 6 . In general, human hematopoietic stem cell (HSC)-grafted immunodeficient mice have poor human T cell development. Although some human T cell reconstitution was seen in NOD/SCID/γc null mice after human umbilical cord blood (UCB) stem cell transplantation, human thymopoiesis in the recipient thymus appeared inefficient, and the mouse thymus remained underdeveloped in these mice 5 . Recently, Traggiai E et al. reported that intrahepatic injection of human CD34 + UCB cells into newborn Rag2
-/-γc -/-mice results in improved human T cell development in the mouse thymus 6 . An important advancement in this model compared to UCB transplantation in adult mice was the ability of grafted mice to mediate in vivo anti-viral immune responses 6 . However, a long period of time (16 weeks) was required to achieve significant peripheral human T cell repopulation in these mice and the levels of human T cells in the spleen of long-term surviving mice were relatively low. Furthermore, the MHC restriction and tolerance status of human T cells that were selected in the mouse thymus in these mice still remains undefined.
A commonly used mouse model for the study of human thymopoiesis and T cell development has been the human-SCID mouse model introduced by McCune et al 1, 7 , in which SCID mice were transplanted with human fetal thymus (Thy) and fetal liver (Liv) tissues. In this model,
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Histological analysis of secondary lymphoid tissues from human fetal Thy/Liv/CD34 + FLCgrafted NOD/SCID mice
We next analyzed human T cell, B cell, and DC repopulation in secondary lymphoid tissues by histology. H&E staining showed numerous erythroblasts (which are stained dark blue and morphologically resembles lymphocytes) and no follicular structure in the spleens of the control NOD/SCID mice ( Fig. 2A ). In the spleens of human Thy/Liv/CD34 + FLC-grafted mice, while typical splenic structure was not identified, erythroblasts were replaced by lymphocytes, and white pulp-like structures characterized by the accumulation of lymphocytes around the central (Fig. 2E) . However, follicular structure was not detected in the lymph nodes from these mice ( Fig. 2C and F) . Our data suggests that the lymph node anlagen formed in the absence of lymphocytes in NOD/SCID mice during organogenesis, but that proper signals such as LT-mediated signals from lymphocytes during early lymph development may be critical for lymph nodes to form and maintain a highly organized microstructure.
Enhanced human immunoglobulin production in NOD/SCID mice transplanted with human fetal Thy/Liv plus CD34 + FLCs
To determine human B cell function, we measured serum human IgM and IgG by ELISA assay (Fig. 3) . Consistent with the level of human B cell repopulation measured by FCM and immunohistochemical analyses ( Fig.1-2 For For 
